China to Eliminate Cancer Drug Import Tariffs
China is one of the world’s largest markets for cancer treatment, with 2016 sales of anti-cancer drugs in the country at 102 billion yuan ($16.2 billion). Photo: VCG
Starting May 1, China will eliminate tariffs on cancer drugs, cutting costs for drug importers.
But whether the move will ease the financial burden on Chinese patients remains to be seen, especially since the value-added tax will drop only slightly.
The State Council, the country’s cabinet, decided during a Thursday meeting (link in Chinese) that anti-cancer drugs will be exempt from import tariffs.
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
RELATED
MOST POPULAR
- 1Veteran China Banker Warns of 'Belt and Road' Risks
- 2Update: China Records First Monthly Trade Deficit in 13 Months
- 3College Told to Suspend Executive MBA Course Over Lax Oversight
- 4China to Open Iron-Ore Futures Market to Foreign Investors in May
- 5After Outcry, Weibo Does U-Turn on Gay Content Ban
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas